摘要
目的:通过观察芪明颗粒对早期糖尿病肾病患者血清胱抑素C与β2微球蛋白的影响,探索其治疗早期糖尿病肾病作用机制。方法:选入符合纳入标准的早期糖尿病肾病患者110例,采用简单随机数字表分为治疗组55例和对照组55例,2组均接受常规的治疗及护理,治疗组给芪明颗粒1袋口服3/日治疗,对照组给予缬沙坦胶囊80 mg口服1/日,治疗16周后观察两组患者血清Cys-C及β2-MG水平的变化,观察两组患者中医症候,统计其临床疗效。结果:治疗组与对照组临床疗效总有效率分别为92.73%、76.36%,比较有显著性差异(P<0.05)。治疗前后两组患者在血清Cys-C及β2-MG方面均有所改善,但是对照组在血清Cys-C及β2-MG方面改善无统计学意义(P>0.05),治疗后治疗组在血清Cys-C及β2-MG方面与对照组比较有显著性差异(P<0.05)。结论:芪明颗粒在改善早期糖尿病肾病中医症候优于对照组,同时也能明显改善血清Cys-C及β2-MG水平,能够延缓糖尿病肾病的发展。芪明颗粒治疗早期糖尿病肾病炎安全有效,为临床广泛应用芪明颗粒提供实验基础。
Objective: To observe the effect of Qiming granule on serum Cystatin C( Cys-C) and beta 2-microglobulin( β2-MG) in patients with early diabetic nephropathy( DN),and to explore its action mechanism when treating early DN. Methods: 110 patients with early DN were randomly divided into the treatment group( n = 55) and the control group( n = 55). The both groups were given routine treatment and care; on which basis,the treatment group was also treated with Qiming Granule( 1 bag/time,3 times/day),whereas the control group was given Valsartan Capsule( 80 mg/time,1 time/day). Serum levels of Cys-C and β2-MG,TCM symptoms were observed in the two groups to assess the clinical efficacy. Results: The total clinical efficacy was respectively 92. 73% and 76. 36% in the treatment group and the control group,of which there was a significant difference( P < 0. 05). Serum levels of Cys-C and β2-MG were both improved after the treatment in the two groups,of which there was a statistical significance between the groups( P < 0. 05);however,there was no significant difference between prior treatment and post treatment in the control group( P > 0. 05).Conclusion: Qiming Granule was superior to Valsartan Capsule in improving TCM symptoms of early DN,it can significantly increase the serum levels of Cys-C and β2-MG,it can delay the development of DN. Qiming Granule is safe and effective in the treatment of early DN,which provides reference for the clinical application of Qiming Granule.
出处
《中医药学报》
CAS
2018年第2期98-101,共4页
Acta Chinese Medicine and Pharmacology
基金
2014年度河北省中医药管理局科学技术课题(2014101)